"NP" is National Post in Canada
NP says Biomira falls, analysts maintain "buy" rating
Biomira Inc BRA-TSE
Shares issued 44,000,000 May 18 close $5.80
Wed 19 May 99 In the News
The National Post reports in its Wednesday edition that pharmaceutical
company Biomira Inc.'s stock fell 15.7 per cent yesterday following news on
Monday that a study suggested treatment with Biomira's Theratope cancer
vaccine following autologous stem cell transplant increases survival and
decreases relapse in ovarian and breast cancer patients. The share price
reached $7.85 last week, its highest level in six months. Yesterday, Ezra
Lwowski, an analyst at Yorkton Securities Inc., maintained a "buy" on the
stock, adding that his target price of $6.50 is under review. Andre Uddin,
an analyst at Merrill Lynch & Co., also maintained a near-term "buy" rating
with a 12-month target price of $10.
the Chief |
